172 related articles for article (PubMed ID: 15715660)
1. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease.
Hsu M; Srinivas B; Kumar J; Subramanian R; Andersen J
J Neurochem; 2005 Mar; 92(5):1091-103. PubMed ID: 15715660
[TBL] [Abstract][Full Text] [Related]
2. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
Chinta SJ; Andersen JK
Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
[TBL] [Abstract][Full Text] [Related]
3. Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease.
Bharath S; Andersen JK
Antioxid Redox Signal; 2005; 7(7-8):900-10. PubMed ID: 15998245
[TBL] [Abstract][Full Text] [Related]
4. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease.
Jha N; Jurma O; Lalli G; Liu Y; Pettus EH; Greenamyre JT; Liu RM; Forman HJ; Andersen JK
J Biol Chem; 2000 Aug; 275(34):26096-101. PubMed ID: 10846169
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and DOPAC-induced cell death: from GSH depletion to mitochondrial energy crisis.
Nunes C; Barbosa RM; Almeida L; Laranjinha J
Mol Cell Neurosci; 2011 Sep; 48(1):94-103. PubMed ID: 21708261
[TBL] [Abstract][Full Text] [Related]
6. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain.
Madrigal JL; Olivenza R; Moro MA; Lizasoain I; Lorenzo P; Rodrigo J; Leza JC
Neuropsychopharmacology; 2001 Apr; 24(4):420-9. PubMed ID: 11182537
[TBL] [Abstract][Full Text] [Related]
7. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease.
Shen XM; Li H; Dryhurst G
J Neural Transm (Vienna); 2000; 107(8-9):959-78. PubMed ID: 11041275
[TBL] [Abstract][Full Text] [Related]
8. Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: a dynamic model.
Vali S; Mythri RB; Jagatha B; Padiadpu J; Ramanujan KS; Andersen JK; Gorin F; Bharath MM
Neuroscience; 2007 Nov; 149(4):917-30. PubMed ID: 17936517
[TBL] [Abstract][Full Text] [Related]
9. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state.
Calabrese V; Mancuso C; Ravagna A; Perluigi M; Cini C; De Marco C; Butterfield DA; Stella AM
J Neurochem; 2007 May; 101(3):709-17. PubMed ID: 17241115
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of gamma-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson's disease.
Chinta SJ; Kumar JM; Zhang H; Forman HJ; Andersen JK
Free Radic Biol Med; 2006 May; 40(9):1557-63. PubMed ID: 16632116
[TBL] [Abstract][Full Text] [Related]
11. Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease.
Kumar MJ; Nicholls DG; Andersen JK
J Biol Chem; 2003 Nov; 278(47):46432-9. PubMed ID: 12963742
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.
Khan FH; Sen T; Maiti AK; Jana S; Chatterjee U; Chakrabarti S
Biochim Biophys Acta; 2005 Jun; 1741(1-2):65-74. PubMed ID: 15925494
[TBL] [Abstract][Full Text] [Related]
13. Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease?
Jha N; Kumar MJ; Boonplueang R; Andersen JK
J Neurochem; 2002 Feb; 80(4):555-61. PubMed ID: 11841562
[TBL] [Abstract][Full Text] [Related]
14. Implications of enzyme deficiencies on mitochondrial energy metabolism and reactive oxygen species formation of neurons involved in rotenone-induced Parkinson's disease: a model-based analysis.
Berndt N; Holzhütter HG; Bulik S
FEBS J; 2013 Oct; 280(20):5080-93. PubMed ID: 23937586
[TBL] [Abstract][Full Text] [Related]
15. Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation.
McNaught KS; Jenner P
Biochem Pharmacol; 2000 Oct; 60(7):979-88. PubMed ID: 10974207
[TBL] [Abstract][Full Text] [Related]
16. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration.
Chinta SJ; Kumar MJ; Hsu M; Rajagopalan S; Kaur D; Rane A; Nicholls DG; Choi J; Andersen JK
J Neurosci; 2007 Dec; 27(51):13997-4006. PubMed ID: 18094238
[TBL] [Abstract][Full Text] [Related]
17. Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson's disease.
Mallajosyula JK; Chinta SJ; Rajagopalan S; Nicholls DG; Andersen JK
Neurotox Res; 2009 Oct; 16(3):186-93. PubMed ID: 19526285
[TBL] [Abstract][Full Text] [Related]
18. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies.
Jagatha B; Mythri RB; Vali S; Bharath MM
Free Radic Biol Med; 2008 Mar; 44(5):907-17. PubMed ID: 18166164
[TBL] [Abstract][Full Text] [Related]
19. Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease.
Chinta SJ; Andersen JK
Free Radic Res; 2011 Jan; 45(1):53-8. PubMed ID: 20815786
[TBL] [Abstract][Full Text] [Related]
20. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex.
Li H; Dryhurst G
J Neural Transm (Vienna); 2001; 108(12):1363-74. PubMed ID: 11810401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
